What's Happening With Baudax Bio Shares Today
Portfolio Pulse from Vandana Singh
Baudax Bio Inc (BXRX) shares surged after the company announced the acquisition of TeraImmune, a biotechnology company focused on Treg-based cell therapies for autoimmune diseases. The merger adds TeraImmune's TI-168 asset to Baudax's portfolio, a promising cell therapy candidate for Hemophilia A patients. Baudax Bio also plans to continue the development of its existing Neuromuscular Blockade (NMB) portfolio.
June 30, 2023 | 5:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baudax Bio's acquisition of TeraImmune and the addition of a promising cell therapy candidate to its portfolio has led to a surge in its share price.
The acquisition of TeraImmune by Baudax Bio is a significant development for the company as it adds a promising cell therapy candidate to its portfolio. This has been positively received by the market, leading to a surge in Baudax Bio's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100